These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31408634)

  • 1. Alteration of Physicochemical Properties for Antibody-Drug Conjugates and Their Impact on Stability.
    Buecheler JW; Winzer M; Weber C; Gieseler H
    J Pharm Sci; 2020 Jan; 109(1):161-168. PubMed ID: 31408634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical Stability Studies of Antibody-Drug Conjugates (ADCs) Under Stressed Conditions.
    Adem YT
    Methods Mol Biol; 2020; 2078():301-311. PubMed ID: 31643066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability.
    Singh SK; Luisi DL; Pak RH
    Pharm Res; 2015 Nov; 32(11):3541-71. PubMed ID: 25986175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-drug conjugates: recent advances in conjugation and linker chemistries.
    Tsuchikama K; An Z
    Protein Cell; 2018 Jan; 9(1):33-46. PubMed ID: 27743348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical and Chemical Stability of Antibody Drug Conjugates: Current Status.
    Ross PL; Wolfe JL
    J Pharm Sci; 2016 Feb; 105(2):391-397. PubMed ID: 26869406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Payload Hydrophobicity on the Stability of Antibody-Drug Conjugates.
    Buecheler JW; Winzer M; Tonillo J; Weber C; Gieseler H
    Mol Pharm; 2018 Jul; 15(7):2656-2664. PubMed ID: 29809017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biophysical Properties and Heating-Induced Aggregation of Lysine-Conjugated Antibody-Drug Conjugates.
    Gandhi AV; Arlotta KJ; Chen HN; Owen SC; Carpenter JF
    J Pharm Sci; 2018 Jul; 107(7):1858-1869. PubMed ID: 29626535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinctive Low-Resolution Structural Features of Dimers of Antibody-Drug Conjugates and Parent Antibody Determined by Small-Angle X-ray Scattering.
    Law-Hine D; Rudiuk S; Bonestebe A; Ienco R; Huille S; Tribet C
    Mol Pharm; 2019 Dec; 16(12):4902-4912. PubMed ID: 31618040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling of hydrophobic interaction chromatography for the separation of antibody-drug conjugates and its application towards quality by design.
    Andris S; Hubbuch J
    J Biotechnol; 2020 Jun; 317():48-58. PubMed ID: 32361022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design, biophysical and biological characterization of site-specific antibody-tubulysin conjugates with improved stability, efficacy and pharmacokinetics.
    Thompson P; Fleming R; Bezabeh B; Huang F; Mao S; Chen C; Harper J; Zhong H; Gao X; Yu XQ; Hinrichs MJ; Reed M; Kamal A; Strout P; Cho S; Woods R; Hollingsworth RE; Dixit R; Wu H; Gao C; Dimasi N
    J Control Release; 2016 Aug; 236():100-16. PubMed ID: 27327768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Properties of Cysteine-Conjugated Antibody-Drug Conjugates Are Impacted by the IgG Subclass.
    Datta-Mannan A; Choi H; Stokell D; Tang J; Murphy A; Wrobleski A; Feng Y
    AAPS J; 2018 Sep; 20(6):103. PubMed ID: 30255287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Chemical Design and Synthesis of Linkers Used in Antibody Drug Conjugates.
    Frigerio M; Kyle AF
    Curr Top Med Chem; 2017; 17(32):3393-3424. PubMed ID: 29357801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggregation of Antibody Drug Conjugates at Room Temperature: SAXS and Light Scattering Evidence for Colloidal Instability of a Specific Subpopulation.
    Frka-Petesic B; Zanchi D; Martin N; Carayon S; Huille S; Tribet C
    Langmuir; 2016 May; 32(19):4848-61. PubMed ID: 27129612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cleavable linkers in antibody-drug conjugates.
    Bargh JD; Isidro-Llobet A; Parker JS; Spring DR
    Chem Soc Rev; 2019 Aug; 48(16):4361-4374. PubMed ID: 31294429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-drug conjugates- stability and formulation.
    Duerr C; Friess W
    Eur J Pharm Biopharm; 2019 Jun; 139():168-176. PubMed ID: 30940541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical de-conjugation for investigating the stability of small molecule drugs in antibody-drug conjugates.
    Chen T; Su D; Gruenhagen J; Gu C; Li Y; Yehl P; Chetwyn NP; Medley CD
    J Pharm Biomed Anal; 2016 Jan; 117():304-10. PubMed ID: 26406314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs.
    Behrens CR; Ha EH; Chinn LL; Bowers S; Probst G; Fitch-Bruhns M; Monteon J; Valdiosera A; Bermudez A; Liao-Chan S; Wong T; Melnick J; Theunissen JW; Flory MR; Houser D; Venstrom K; Levashova Z; Sauer P; Migone TS; van der Horst EH; Halcomb RL; Jackson DY
    Mol Pharm; 2015 Nov; 12(11):3986-98. PubMed ID: 26393951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Linker-Drug Properties and Conjugation Site on the Physical Stability of ADCs.
    Mills BJ; Kruger T; Bruncko M; Zhang X; Jameel F
    J Pharm Sci; 2020 May; 109(5):1662-1672. PubMed ID: 32027921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical methods for physicochemical characterization of antibody drug conjugates.
    Wakankar A; Chen Y; Gokarn Y; Jacobson FS
    MAbs; 2011; 3(2):161-72. PubMed ID: 21441786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Chemical Approaches for Site-Specific Conjugation of Native Antibodies: Technologies toward Next-Generation Antibody-Drug Conjugates.
    Yamada K; Ito Y
    Chembiochem; 2019 Nov; 20(21):2729-2737. PubMed ID: 30973187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.